Cytoreductive surgery for stage IV renal cell carcinoma.

No abstract is available for this paper.

• Publication year

  1995

• Venue

  Journal of Urology

• Publication date

  1995-07-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S0022-5347(01)67217-3PMID 7776449
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma.

  1994cited by this paper
• The impact of adjuvant nephrectomy on multimodality treatment of metastatic renal cell carcinoma.

  1994cited by this paper
• Cytoreductive surgery before high dose interleukin-2 based therapy in patients with metastatic renal cell carcinoma.

  1993cited by this paper
• Cytoreductive surgery prior to interleukin-2-based therapy in patients with metastatic renal cell carcinoma.

  1993cited by this paper
• Interleukin-2 immunotherapy followed by resection of residual renal cell carcinoma.

  1991cited by this paper
• Circadian-shaped infusions of floxuridine for progressive metastatic renal cell carcinoma.

  1990cited by this paper
• Combination therapy with interleukin-2 and alpha-interferon for the treatment of patients with advanced cancer.

  1989cited by this paper
• Experience with the Use of High‐Dose Interleukin‐2 in the Treatment of 652 Cancer Patients

  1989cited by this paper
• Metastatic renal cancer treated with interleukin-2 and lymphokine-activated killer cells. A phase II clinical trial.

  1988cited by this paper
• Interferon therapy of metastatic renal cell cancer.

  1988cited by this paper
• Laparotomy enhances intraperitoneal tumor growth and abrogates the antitumor effects of interleukin-2 and lymphokine-activated killer cells.

  1987cited by this paper
• Interferon therapy for renal cell carcinoma.

  1987cited by this paper
• Correlation of computerized tomographic changes and histological findings in 80 patients having radical retroperitoneal lymph node dissection after chemotherapy for testis cancer.

  1987cited by this paper
• Treatment of advanced renal cell carcinoma.

  1982cited by this paper
• Liver Metastases.

  1981cited by this paper
• Surgical resection for metastatic neoplasms of the lung: Experience at the university of minnesota hospitals

  1980cited by this paper
• The contribution of surgery to the management of carcinomatous pulmonary metastases

  1978cited by this paper
• Is nephrectomy justified in patients with metastatic renal carcinoma?

  1975cited by this paper
• Diagnosis and management of renal cell carcinoma A clinical and pathologic study of 309 cases

  1971cited by this paper
• Surgery for metastatic renal cell carcinoma.

  1967cited by this paper

• A dynamic visualization clinical tool constructed and validated based on the SEER database for screening the optimal surgical candidates for bone metastasis in primary kidney cancer

  2024cites this paper
• Understanding and integrating cytoreductive nephrectomy with immune checkpoint inhibitors in the management of metastatic RCC

  2023cites this paper
• Is Cytoreductive Nephrectomy Still Beneficial for Patients With Metastatic Renal Cell Carcinoma in the Contemporary Immunotherapy Era?

  2022cites this paper
• The current role of cytoreductive nephrectomy for metastatic renal cell carcinoma

  2021cites this paper
• Choice of Surgical Options in Kidney Cancer and Surgical Complications.

  2020cites this paper
• Renal Cell Carcinoma: Recent Progress and Future Directions1

  2019cites this paper
• The use of cytoreductive nephrectomy in patients with renal cell carcinoma

  2019cites this paper
• Defining an Individualized Treatment Strategy for Metastatic Renal Cancer

  2019cites this paper
• 2 Role of Laparoscopic Nephrectomy in Metastatic Renal Cell Carcinoma

  2017cites this paper
• Surgical management of metastatic renal cell carcinoma.

  2017cites this paper
• Cytoreductive therapy in the era of targeted therapies: a review

  2017cites this paper
• Renal Cell Carcinoma : Recent Progress and Future Directions 1

  2017cites this paper
• Surgical Management of Advanced and Metastatic Renal Cell Carcinoma: A Multidisciplinary Approach

  2017cites this paper
• The independent oncological role for cytoreductive nephrectomy in metastatic renal cell carcinoma: Prognostic features in the era of targeted therapies.

  2017cites this paper
• Cytoreductive nephrectomy in the era of targeted therapies: a review

  2017cites this paper
• Cytoreductive nephrectomy for metastatic renal cell carcinoma.

  2016cites this paper
• Cytoreductive nephrectomy and its role in the present-day period of targeted therapy

  2015cites this paper
• Cytoreductive Nephrectomy for Metastatic Renal Cell Carcinoma: A Review of the Historical Literature and Its Role in the Era of Targeted Molecular Therapy

  2014cites this paper
• Cytoreductive nephrectomy for metastatic renal cell carcinoma in the era of targeted therapy in the United States: a SEER analysis

  2013cites this paper
• Consolidative surgery after targeted therapy for renal cell carcinoma.

  2013cites this paper
• Cytoreductive radiofrequency ablation in patients with metastatic renal cell carcinoma (RCC) with small primary tumours treated with sunitinib or interferon‐α

  2013cites this paper
• Chemotherapy, Targeted Therapies, and Biological Therapies for Renal Cell Carcinoma

  2013cites this paper
• Defining an individualized treatment strategy for metastatic renal cancer.

  2012cites this paper
• Treatment of Advanced Renal Cell Carcinoma

  2012cites this paper
• Malignant Renal Tumors

  2012cites this paper
• Management of kidney cancer in Asia: resource-stratified guidelines from the Asian Oncology Summit 2012.

  2012cites this paper
• Contemporary Management in Metastatic Renal Cell Carcinoma

  2012cites this paper
• Management of prostate cancer in Asia: resource-stratified guidelines from the Asian Oncology Summit 2013.

  2012cites this paper
• Cytoreductive nephrectomy for pT3b–T4 M1 renal cell carcinoma in 39 patients: Single center analysis

  2012cites this paper
• New surgical horizons: the role of cytoreductive nephrectomy for metastatic kidney cancer.

  2012cites this paper
• Trends in the use of cytoreductive nephrectomy in the United States.

  2012cites this paper
• Renal Cell Carcinoma

  2011cites this paper
• Mortality and Morbidity After Cytoreductive Nephrectomy for Metastatic Renal Cell Carcinoma: A Population-Based Study

  2011cites this paper
• Renal Neoplasia

  2011cites this paper
• Surgical management of large renal tumors

  2011cites this paper
• Cytoreductive Nephrectomy Preceding Adjuvant Immunotherapy for Metastatic Renal Cell Carcinoma: 8 Years' Experience in a UK Tertiary Referral Centre

  2011cites this paper
• Place de la chirurgie (néphrectomie cytoréductrice et métastasectomie) dans la prise en charge du cancer du rein métastatique : revue de la littérature

  2010cites this paper
• Role of surgery in advanced/metastatic renal cell carcinoma

  2010cites this paper
• La néphrectomie est-elle indispensable en cas de métastases ?

  2010cites this paper
• [Is the cytoreductive nephrectomy still necessary in case of metastases?].

  2010cites this paper
• Treatment of metastatic renal cell carcinoma

  2010cites this paper
• [Role of surgery (cytoreductive nephrectomy and metastasectomy) in the management of metastatic renal cell carcinoma: a literature review].

  2010cites this paper
• Is there a role for presurgical therapy for renal cell carcinoma?

  2010cites this paper
• Role of cytoreductive nephrectomy in renal cell carcinoma.

  2009cites this paper
• The role of cytoreductive nephrectomy in the era of molecular targeted therapy

  2009cites this paper
• Cytoreductive nephrectomy for kidney cancer with sarcomatoid histology--is up-front resection indicated and, if not, is it avoidable?

  2009cites this paper
• Cytoreductive nephrectomy in metastatic renal cell carcinoma: the evolving role of surgery in the era of molecular targeted therapy

  2009cites this paper
• Cytoreductive nephrectomy for metastatic RCC in the era of targeted therapy

  2009cites this paper
• Multimodality treatment paradigms for renal cell carcinoma: surgery versus targeted agents

  2009cites this paper
• The contemporary role of surgery in kidney cancer

  2009cites this paper
• Use of systemic therapy and factors affecting survival for patients undergoing cytoreductive nephrectomy

  2009cites this paper
• Pre‐surgical targeted molecular therapy in renal cell carcinoma

  2009cites this paper
• Integration of surgery and systemic therapy in the management of metastatic renal cancer

  2009cites this paper
• Cytoreductive nephrectomy in metastatic renal cell carcinoma

  2008cites this paper
• The once and future role of cytoreductive nephrectomy.

  2008cites this paper
• Cytokine Therapy Response as a Selection Criterion for Cytoreductive Nephrectomy in Metastatic Renal Clear-Cell Carcinoma of Intermediate Prognosis

  2008cites this paper
• Advanced Disease: Nonpulmonary Metastases

  2008cites this paper
• The Role of Metastasectomy and Immunochemotherapy in Multimodal Therapy for Metastatic Renal Cell Carcinoma

  2008cites this paper
• Nephrectomy in Patients with Metastatic Renal Cell Carcinoma: Clinical and Biologic Effects

  2008cites this paper
• Nefrectomia citorredutora em câncer renal metastático

  2008cites this paper
• Papel de la nefrectomía en el tratamiento de los cánceres renales metastásicos

  2007cites this paper
• Outcome after cytoreductive nephrectomy for metastatic renal cell carcinoma is predicted by fractional percentage of tumour volume removed

  2007cites this paper
• Interleukin-2 based immunotherapy in patients with metastatic renal cell carcinoma.

  2007cites this paper
• Cytoreductive Nephrectomy for Metastatic Renal Cell Carcinoma: Is It Still Imperative in the Era of Targeted Therapy?

  2007cites this paper
• Current status of cytoreductive nephrectomy in metastatic renal cell carcinoma

  2007cites this paper
• Surgical management of renal cell carcinoma.

  2006cites this paper
• Interferon alpha 2b as medical selection for nephrectomy in patients with synchronous metastatic renal cell carcinoma: a consecutive study.

  2006cites this paper
• Metastatectomy prior to Immunochemotherapy for Metastatic Renal Cell Carcinoma

  2006cites this paper
• Laparoscopic cytoreductive nephrectomy: the M. D. Anderson Cancer Center experience.

  2006cites this paper
• [Role of nephrectomy in metastatic renal cell carcinoma].

  2006cites this paper
• Cytoreductive nephrectomy in metastatic renal cell carcinoma

  2006cites this paper
• Prognostic factors and the role of neprectomy in metastatic renal cell carcinoma

  2006cites this paper
• Epidemiological and clinical aspects in diagnosis and treatment of renal cell carcinoma

  2006cites this paper
• Place de la néphrectomie dans la prise en charge des cancers du rein métastatiques

  2006cites this paper
• Interferon alpha 2b as medical selection for nephrectomy in patients with synchronous metastatic renal cell carcinoma : a consecutive study

  2006cites this paper
• Combination of surgery and immunotherapy in metastatic renal cell carcinoma

  2005cites this paper
• Novel therapies for advanced renal cell carcinoma

  2005cites this paper
• Surgery for metastatic renal cell cancer

  2005cites this paper
• Solitary Bony Metastasis from Renal Cell Carcinoma: Significance of Surgical Treatment

  2005cites this paper
• Salvage Surgery for Advanced Renal Cell Carcinoma

  2004cites this paper
• Does Radical Nephrectomy with Immunochemotherapy Have Any Superiority over Embolization Alone in Metastatic Renal Cell Carcinoma?

  2004cites this paper
• Natural and Clinical Course of Renal Cell Carcinoma — Better Prospect for the Patients

  2004cites this paper
• Role of Laparoscopic Nephrectomy in Metastatic Renal Cell Carcinoma

  2004cites this paper
• Changing concepts in the surgical management of renal cell carcinoma.

  2004cites this paper
• Debulking Nephrectomy in Metastatic Renal Cancer

  2004cites this paper
• Surgical Treatment of Advanced Disease for Renal Cell Cancer

  2003cites this paper
• The role of cytoreductive nephrectomy in the management of metastatic renal cell carcinoma.

  2003cites this paper
• Cytoreductive nephrectomy in metastatic renal cancer

  2003cites this paper
• Role of nephrectomy in metastatic kidney cancer.

  2003cites this paper
• The Timing of Immunotherapy and Nephrectomy in Multimodality Treatment of Metastatic Renal Cell Carcinoma

  2003cites this paper
• Prognostic factors for biologic therapy in kidney cancer

  2002cites this paper
• Principles of nephrectomy for malignant disease

  2002cites this paper
• [The value of tumor nephrectomy in metastatic renal cell carcinoma].

  2002cites this paper
• Multimodality treatment of metastatic renal cell carcinoma

  2002cites this paper
• Stellenwert der Tumornephrektomie beim metastasierten Nierenzellkarzinom

  2002cites this paper
• The role of initial immunotherapy as selection for nephrectomy in patients with metastatic renal cell carcinoma and the primary tumor in situ.

  2002cites this paper
• The role of resection for patients with renal carcinoma

  2001cites this paper
• Renal Cancer: Methods and Protocols

  2001cites this paper
• Urologic Approaches to Metastatic Renal Cell Carcinoma

  2001cites this paper
• Radical nephrectomy plus interferon-alfa-based immunotherapy compared with interferon alfa alone in metastatic renal-cell carcinoma: a randomised trial.

  2001cites this paper